Landiolol for junctional ectopic tachycardia refractory to amiodarone after pediatric cardiac surgery

Tomomi Hasegawa1, Yoshihiro Oshima, Ayako Maruo

  • 1Department of Cardiovascular Surgery, Kobe Children's Hospital, 1-1-1 Takakuradai, Suma-ku, Kobe 654-0081, Japan. tohasegawa_kch@hp.pref.hyogo.jp

Insights

Postoperative junctional ectopic tachycardia (JET) in children is a serious risk after heart surgery. Low-dose landiolol effectively treated a refractory case in an infant, restoring stable heart rhythms.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Clinical Pharmacology

Background:

  • Postoperative junctional ectopic tachycardia (JET) is a significant complication in pediatric cardiac surgery.
  • JET can lead to severe hemodynamic instability, morbidity, and mortality in infants.
  • Standard antiarrhythmic therapies may be ineffective in refractory cases.

Observation:

  • A 3-month-old infant developed refractory JET post-ventricular septal defect closure and right pulmonary artery plasty.
  • The infant experienced severe hypotension requiring cardiac massage despite amiodarone treatment.
  • Poor left ventricular function complicated the postoperative course.

Findings:

  • Continuous intravenous infusion of low-dose landiolol was administered.
  • Landiolol rapidly reduced the JET rate and restored sinus rhythm.
  • Hemodynamic stability was achieved following landiolol therapy.

Implications:

  • Landiolol represents a potential therapeutic option for refractory postoperative JET in pediatric cardiac surgery patients.
  • This case highlights the efficacy of landiolol in managing severe arrhythmias in infants with compromised cardiac function.
  • Further research into landiolol's role in pediatric cardiac critical care is warranted.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...